Stanley Hostler - Protea Biosciences Insider

Protea Biosciences Group Inc -- USA Stock  

USD 0.035  0.005  12.50%

VP, Secretary, Director and Member of Audit Committee

Mr. Stanley Hostler is Vice President, Secretary, Director of the Company. He was a Director of the Company since January 2006 and Vice President and Secretary since June 2006. Mr. Hostler is an attorney with a career practice in the field of labor and employment law. From 2000 to 2010 he served as Special Assistant to the Governor of the State of West Virginia. From 2002 to 2004 he served as Counsel to the Prim Law Firm. From 2000 to 2010 he served on the West Virginia University Foundation Board of Directors, and from 1995 to 2010 on the Advisory Committee of the WVU School of Medicine. He is a Graduate of the West Virginia University School of Law . Mr. Hostlers legal experience and business contacts and relationships with West Virginia University and the State of West Virginia have been an asset to the Company and led the board to determine that he should serve as a director of the Company.
Age: 86        

Stanley Hostler Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (104.33) % which means that it has lost $104.33 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (31.9) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 10.93 M in liabilities. Protea Biosciences Group Inc has Current Ratio of 0.04 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.

Similar Executives

Showing few of many executives


Adam LogalVBI Vaccines Inc
Henry JiNantKwest Inc
John PottsNantKwest Inc
Scott RequadtVBI Vaccines Inc
Dennis BrownDelMar Pharmaceuticals Inc
William GarnerDelMar Pharmaceuticals Inc
Michael BlaszykNantKwest Inc
Alan ColowickDimension Therapeutics Inc
Kate InmanVBI Vaccines Inc
Ruth AlonVascular Biogenics Ltd
Arlene MorrisDimension Therapeutics Inc
Tomer KarivVBI Vaccines Inc
Robert RosenNantKwest Inc
Alan TimminsVBI Vaccines Inc
Philip SerlinVascular Biogenics Ltd
Michael DybbsDimension Therapeutics Inc
Sam ChawlaVBI Vaccines Inc
Lynda CranstonDelMar Pharmaceuticals Inc
Dan GelvanVascular Biogenics Ltd
Georges GemayelDimension Therapeutics Inc
Saiid ZarrabianDelMar Pharmaceuticals Inc

Entity Summary

Protea Biosciences Group, Inc., a molecular information company, develops and commercializes proprietary life science technologies, products, and services to identify the molecules that are produced by living cells and various life forms. Protea Biosciences Group Inc (PRGB) is traded on OTC Market in USA. It is located in WEST VIRGINIA, U.S.A and employs 35 people. Protea Biosciences is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Commodity Channel Index Now

Commodity Channel Index

Use Commodity Channel Index to analyze current equity momentum
Hide  View All  NextLaunch Commodity Channel Index

Fix Portfolio

Optimize Your Risk-Return Tradeoff
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Protea Biosciences Group Inc to your portfolio

Top Management

Protea Biosciences G Leadership Team
Leonard Harris, Director
Stephen Turner, Chairman
Gregory Kilby, COO, Ph.D
Edwin Roberson, Director
Stanley Hostler, Director
Steven Antoline, Director
Edward Hughes, CFO
Scott Segal, Director
Ed Roberson, Director
Patrick Gallagher, Director, CFA
Andrew Zulauf, Director, MBA
Josiah Austin, Director
Matthew Powell, VP, Ph.D
David Halverson, President
Maged Shenouda, Director, MBA

Stock Performance

Protea Biosciences Performance Indicators